SAR156597
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for SAR156597, covering 2016-02-15 to 2022-02-02. Get the full timeline:
Most recent: Clinical Trial Update: Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis [Phase 2]